Evaluation of safety, tolerability and pharmacokinetics (PK) of patupilone in patients (pts) with advanced solid tumors and varying degrees of hepatic function: An open-label phase I study

被引：3
|
作者：
Reid, T. R.
Takimoto, C. H.
Verschraegen, C. F.
Sarantopoulos, J.
Cheung, W.
Allen-Freda, E.
Li, J.
Xu, Y.
Ko, J.
Johri, A.
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] START, San Antonio, TX USA
[3] Univ New Mexico, Albuquerque, NM 87131 USA
[4] CTRC Inst Drug Dev, San Antonio, TX USA
[5] Novartis, Florham Pk, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.2557
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2557
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evaluation of pharmacokinetics (PK) and pharmacodynamics (PD) of patupilone and warfarin in patients (pts) with advanced solid tumors: An open-label, phase I study
    Takimoto, C. H.
    Fu, S.
    Dhillon, N.
    Mita, M. M.
    Mita, A. C.
    Cheung, W.
    Xu, Y.
    Ali, A.
    Johri, A.
    Kurzrock, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
    Sunil Sharma
    Petronella O. Witteveen
    Martijn P. Lolkema
    Dagmar Hess
    Hans Gelderblom
    Syed A. Hussain
    Maria G. Porro
    Edward Waldron
    Sue-zette Valera
    Song Mu
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 87 - 95
  • [3] A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
    Sharma, Sunil
    Witteveen, Petronella O.
    Lolkema, Martijn P.
    Hess, Dagmar
    Gelderblom, Hans
    Hussain, Syed A.
    Porro, Maria G.
    Waldron, Edward
    Valera, Sue-zette
    Mu, Song
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (01) : 87 - 95
  • [4] A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
    Slingerland, Marije
    Hess, Dagmar
    Clive, Sally
    Sharma, Sunil
    Sandstrom, Per
    Loman, Niklas
    Porro, Maria G.
    Mu, Song
    Waldron, Edward
    Valera, Sue-zette
    Gelderblom, Hans
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 1089 - 1098
  • [5] A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
    Marije Slingerland
    Dagmar Hess
    Sally Clive
    Sunil Sharma
    Per Sandstrom
    Niklas Loman
    Maria G. Porro
    Song Mu
    Edward Waldron
    Sue-zette Valera
    Hans Gelderblom
    [J]. Cancer Chemotherapy and Pharmacology, 2014, 74 : 1089 - 1098
  • [6] A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment
    Saif, Muhammad Wasif
    Becerra, Carlos R.
    Fakih, Marwan G.
    Sun, Weijing
    Popovic, Lazar
    Krishnamurthi, Smitha
    George, Thomas J.
    Rudek, Michelle A.
    Shepard, Dale R.
    Skopek, Jiri
    Sramek, Vladimir
    Zaric, Bojan
    Yamamiya, Ikuo
    Benhadji, Karim A.
    Hamada, Kensuke
    He, Yaohua
    Rosen, Lee
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (03) : 485 - 497
  • [7] A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment
    Muhammad Wasif Saif
    Carlos R. Becerra
    Marwan G. Fakih
    Weijing Sun
    Lazar Popovic
    Smitha Krishnamurthi
    Thomas J. George
    Michelle A. Rudek
    Dale R. Shepard
    Jiri Skopek
    Vladimir Sramek
    Bojan Zaric
    Ikuo Yamamiya
    Karim A. Benhadji
    Kensuke Hamada
    Yaohua He
    Lee Rosen
    [J]. Cancer Chemotherapy and Pharmacology, 2021, 88 : 485 - 497
  • [8] Pharmacokinetics (PK) and safety of carfilzomib (CFZ) in patients (Pts) with advanced malignancies and varying degrees of hepatic impairment (HI): an open-label, single-arm, phase 1 study
    Brown, J.
    Plummer, R.
    Bauer, T. M.
    Anthony, S.
    Sarantopoulos, J.
    De Vos, F.
    White, M.
    Schupp, M.
    Ou, Y.
    Vaishampayan, U.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [9] Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors
    Gordon, Michael S.
    Nemunaitis, John
    Barve, Minal
    Wainberg, Zev A.
    Hamilton, Erika P.
    Ramanathan, Ramesh K.
    Sledge, George W., Jr.
    Yue, Huibin
    Morgan-Lappe, Susan E.
    Blaney, Martha
    Kasichayanula, Sreeneeranj
    Motwani, Monica
    Wang, Lan
    Naumovski, Louie
    Strickler, John H.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2021, 20 (10) : 1988 - 1995
  • [10] Safety, tolerability, pharmacokinetics, and antitumour activity of oleclumab in Japanese patients with advanced solid malignancies: a phase I, open-label study
    Kondo, Shunsuke
    Iwasa, Satoru
    Koyama, Takafumi
    Fujita, Tomoko
    Sugibayashi, Ko
    Murayama, Kosho
    Yamamoto, Noboru
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (12) : 1795 - 1804
12345